Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Filings indexed 2,766 across all filing types
Latest filing 2023-02-15 Capital/Financing Update
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
424B2
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(2) related to a $6 billion offering of senior notes by CVS Health Corporation. It details the terms of the debt securities, including interest rates, maturity dates, underwriting discounts, and legal disclaimers. The document is a formal offering prospectus supplement, which is a type of capital markets document used to inform investors about a new debt issuance. It is not a financial report, earnings release, management discussion, or any other type of corporate filing. The content clearly relates to financing activities and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the actual offering document, not just an announcement or a brief notice.
2023-02-15 English
FWP
Capital/Financing Update Classification · 95% confidence The document is a Free Writing Prospectus (FWP) filed pursuant to Rule 433, related to a securities offering by CVS Health Corporation. It details the pricing term sheet for senior notes with specific terms such as maturity dates, coupon rates, issue prices, and underwriting information. This type of document is an update or supplement to a prospectus related to capital raising activities. It is not a financial report, earnings release, or management discussion. It is clearly related to financing and capital markets activity, specifically the issuance of debt securities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a mere announcement but a detailed term sheet, supporting a high confidence score.
2023-02-13 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(3) related to a registration statement under the Securities Act of 1933. It details the terms of a senior notes offering by CVS Health Corporation, including interest rates, maturity dates, underwriting details, and legal disclaimers. The document is a formal offering prospectus supplement, which is a type of capital raising document describing financing activities. It is not an annual report, earnings release, or any other type of financial report. It is clearly related to a capital/financing update regarding debt issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual offering document, not just an announcement or a regulatory filing.
2023-02-13 English
Regulatory Filings 2023
Regulatory Filings
2023-02-10 English
SCHEDULE 13G/A
Major Shareholding Notification
2023-02-09 English
PROXY STATEMENT PURSUANT TO SECTION 14(A)
Proxy Solicitation & Information Statement
2023-02-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.